Bawa, Zeeta
McCartney, Danielle
Manocha, Ramesh
McGregor, Iain S.
Article History
Received: 30 September 2022
Accepted: 9 December 2022
First Online: 19 December 2022
Declarations
:
: Ethics approval was granted by the University of Sydney Human Research Ethics Committee on September 17, 2021 (Ref: 2021/623) for this cross-sectional survey. All participants provided consent prior to completing the questionnaire. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Authors ZB and DM declare they have no financial interests. ISM has received honoraria from Janssen, is currently a consultant to Kinoxis Therapeutics, and has received research funding and fellowship support from the Lambert Initiative, NHMRC and Australian Research Council. He holds a variety of patents for non-cannabinoid therapeutics. This survey was conducted at an online seminar run by Healthed and RM is the CEO of Healthed.